loader
Please Wait
Applying Filters...

Seqens Seqens

X

Technical details about 2-Naphthalenepropanoic Acid, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
Also known as: Dx-9065a, 155204-81-2, Qxqvepevi2, Dx-9065a hcl hydrate, 155204-81-2 (hcl, hydrate), X-9065a
Molecular Formula
C26H39ClN4O8
Molecular Weight
571.1  g/mol
InChI Key
LJCBAPRMNYSDOP-LVCYMWGESA-N
FDA UNII
QXQVEPEVI2

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-[4-[(3S)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic acid;pentahydrate;hydrochloride
2.1.2 InChI
InChI=1S/C26H28N4O3.ClH.5H2O/c1-16(27)30-11-10-23(15-30)33-22-8-6-19(7-9-22)24(26(31)32)13-17-2-3-18-4-5-20(25(28)29)14-21(18)12-17;;;;;;/h2-9,12,14,23-24,27H,10-11,13,15H2,1H3,(H3,28,29)(H,31,32);1H;5*1H2/t23-,24-;;;;;;/m0....../s1
2.1.3 InChI Key
LJCBAPRMNYSDOP-LVCYMWGESA-N
2.1.4 Canonical SMILES
CC(=N)N1CCC(C1)OC2=CC=C(C=C2)C(CC3=CC4=C(C=C3)C=CC(=C4)C(=N)N)C(=O)O.O.O.O.O.O.Cl
2.1.5 Isomeric SMILES
CC(=N)N1CC[C@@H](C1)OC2=CC=C(C=C2)[C@H](CC3=CC4=C(C=C3)C=CC(=C4)C(=N)N)C(=O)O.O.O.O.O.O.Cl
2.2 Other Identifiers
2.2.1 UNII
QXQVEPEVI2
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (2s)-2-(4-(((3s)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic Acid

2. Dx 9065

3. Dx 9065a

4. Dx-9065a

2.3.2 Depositor-Supplied Synonyms

1. Dx-9065a

2. 155204-81-2

3. Qxqvepevi2

4. Dx-9065a Hcl Hydrate

5. 155204-81-2 (hcl, Hydrate)

6. X-9065a

7. Dx 9065a

8. (s)-3-(7-carbamimidoylnaphthalen-2-yl)-2-(4-(((s)-1-(1-iminoethyl)pyrrolidin-3-yl)oxy)phenyl)propanoic Acid Hydrochloride Pentahydrate

9. Dx-9065 Hydrochloride Pentahydrate

10. Unii-qxqvepevi2

11. (s-(r*,r*))-7-(aminoiminomethyl)-alpha-(4-((1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-2-naphthalenepropanoic Acid Monohydrochloride, Pentahydrate

12. Dtxsid60935162

13. (2s)-2-(4-(((3s)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic Acid

14. 2-naphthalenepropanoic Acid, 7-(aminoiminomethyl)-alpha-(4-((1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-, Monohydrochloride, Pentahydrate, (s-(r*,r*))-

15. (+)-(2s)-2-[4-[[(3s)-1-acetimidoyl-3-pyrrolidi-nyl]oxy]phenyl]-3-[7-amidino-2-naphthyl] Propanoic Acid Hydrochloride Pentahydrate

16. (.alpha.s)-7-(aminoiminomethyl)-.alpha.-(4-(((3s)-1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-2-naphthalenepropanoic Acid Hydrochloride Hydrate (1:1:5)

17. (2s)-3-(7-carbamimidoylnaphthalen-2-yl)-2-[4-[(3s)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic Acid;pentahydrate;hydrochloride

18. 2-naphthalenepropanoic Acid, 7-(aminoiminomethyl)-.alpha.-(4-(((3s)-1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-, Hydrochloride, Hydrate (1:1:5), (.alpha.s)-

19. 2-naphthalenepropanoic Acid, 7-(aminoiminomethyl)-.alpha.-(4-(((3s)-1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-, Monohydrochloride, Pentahydrate, (.alpha.s)-

20. 2-naphthalenepropanoic Acid, 7-(aminoiminomethyl)-.alpha.-(4-((1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-, Monohydrochloride, Pentahydrate, (s-(r*,r*))-

21. 2-naphthalenepropanoic Acid,7-(aminoiminomethyl)-a-[4-[[(3s)-1-(1-iminoethyl)-3-pyrrolidinyl]oxy]phenyl]-,hydrochloride,hydrate (1:1:5),(as)-

22. 3-(7-carbamimidoylnaphthalen-2-yl)-2-{4-[(1-ethanimidoylpyrrolidin-3-yl)oxy]phenyl}propanoic Acid--hydrogen Chloride--water (1/1/5)

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 571.1 g/mol
Molecular Formula C26H39ClN4O8
Hydrogen Bond Donor Count10
Hydrogen Bond Acceptor Count10
Rotatable Bond Count8
Exact Mass570.2456419 g/mol
Monoisotopic Mass570.2456419 g/mol
Topological Polar Surface Area129 Ų
Heavy Atom Count39
Formal Charge0
Complexity720
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count7
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Platelet Aggregation Inhibitors

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)


Anticoagulants

Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)


Serine Proteinase Inhibitors

Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)


Post Enquiry
POST ENQUIRY